What does life sciences — income loss on divestitutres net mean?

This metric represents the net gain or loss recognized from the sale or disposal of business units, assets, or product lines within the Life Sciences segment. It captures the financial impact of strategic portfolio optimization and divestiture activities. Investors use this to assess the impact of non-recurring strategic restructuring on segment profitability.

Ashland ASH Life Sciences — Income Loss On Divestitutres Net

Other segment segments

Intermediates And Solvents

$0—

Personal Care And Household

$0—

Specialty Additives

$0—

Unallocated And Other

-$0-100%

Similar metrics at other companies

PTCTLife Science — Net Income Loss

-$2.81M-100%

IIPRLife Science Portfolio Segment: — Net Income

$5.54M—

SONLoss on divestiture of business

-$1.87M+55.4%

DCILife Sciences Segment — Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest

$6.8M+17.2%

BGCGain (loss) on divestitures and sale of investments

$16.68M+72.1%

RBALoss on divestiture and deconsolidation, net

-$2.4M—

Other financials

Income statement

See full

Revenue$482.0M+0.6%

Gross profit$147.0M0.0%

Operating income$39.0M-23.5%

Net income$16.0M-48.4%

EPS (diluted)$0.34-47.7%

Balance sheet

See full

Cash & equivalents$343.0M+104%

Total debt$1.5B-0.6%

Total equity$1.9B-27.1%

Total assets$4.5B-14.0%

Cash flow

See full

Operating cash flow$50.0M+456%

CapEx$17.0M-19.0%

Free cash flow$33.0M+375%

Valuation

See full

Market cap$2.93B-9.0%

Enterprise value$4.06B-10.6%

P/S1.6×0.0×

Profitability

See full

Gross margin30%-1.7pp

Operating margin-37.3%—

Net margin-40.8%-48.8pp

FCF margin13.6%+9.7pp

Returns & leverage

See full

Return on equity-33.4%-38.5pp

Debt / equity0.8×+0.2×

Current ratio3.1×+0.7×

Where this comes from

Reported directly by Ashland in its filing.

Tagged under the XBRL concept ash:IncomeLossOnDivestitutresNet.

The official record: Ashland’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ashland's life sciences — income loss on divestitutres net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ashland's life sciences — income loss on divestitutres net?: Ashland (ASH) reported life sciences — income loss on divestitutres net of $0 in Q1 2026.
What does life sciences — income loss on divestitutres net mean?: This metric represents the net gain or loss recognized from the sale or disposal of business units, assets, or product lines within the Life Sciences segment. It captures the financial impact of strategic portfolio optimization and divestiture activities. Investors use this to assess the impact of non-recurring strategic restructuring on segment profitability.